Peter G. Abram
Financieel Directeur/CFO bij MDS Pharma Services (Canada)
Profiel
Peter G.
Abram is currently the Chief Financial Officer & Senior Vice President at MDS Pharma Services (Canada) since 2005.
Prior to this, he worked as a Manager-Financial Planning & Reporting at General Electric Co. He also served as the Chief Financial Officer & Senior Vice President at FARO Technologies, Inc. from 2014 to 2015.
Mr. Abram completed his undergraduate degree from Miami University.
Actieve functies van Peter G. Abram
| Bedrijven | Functie | Begin |
|---|---|---|
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Financieel Directeur/CFO | 06-09-2005 |
Eerdere bekende functies van Peter G. Abram
| Bedrijven | Functie | Einde |
|---|---|---|
| FARO TECHNOLOGIES, INC. | Financieel Directeur/CFO | 20-03-2015 |
| GE AEROSPACE | Corporate Officer/Principal | - |
Opleiding van Peter G. Abram
| Miami University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| FARO TECHNOLOGIES, INC. | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
MDS Pharma Services (Canada)
MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Commercial Services |